DSUR Submission Delays Reported as Regulatory Observations
DSUR Submission Delays Reported as Regulatory Observations Why DSUR Submission Delays Are a Frequent Regulatory Audit Finding Introduction: The Role of DSUR in Clinical Trials The Development Safety Update Report (DSUR) is a critical pharmacovigilance document required annually for investigational products. It provides regulators with a comprehensive review of the global safety profile of the…
Read More “DSUR Submission Delays Reported as Regulatory Observations” »